Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/174369
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Benetó, Noelia | - |
dc.contributor.author | Cozar, Mónica | - |
dc.contributor.author | Castilla-Vallmanya, Laura | - |
dc.contributor.author | Zetterdahl, Oskar G. | - |
dc.contributor.author | Sacultanu, Madalina | - |
dc.contributor.author | Segur-Bailach, Eulalia | - |
dc.contributor.author | García-Morant, María | - |
dc.contributor.author | Ribes, Antonia | - |
dc.contributor.author | Ahlenius, Henrik | - |
dc.contributor.author | Grinberg Vaisman, Daniel Raúl | - |
dc.contributor.author | Vilageliu i Arqués, Lluïsa | - |
dc.contributor.author | Canals Montferrer, Isaac | - |
dc.date.accessioned | 2021-02-25T17:51:23Z | - |
dc.date.available | 2021-02-25T17:51:23Z | - |
dc.date.issued | 2020-02-28 | - |
dc.identifier.issn | 2077-0383 | - |
dc.identifier.uri | http://hdl.handle.net/2445/174369 | - |
dc.description.abstract | Sanfilippo syndrome type C (mucopolysaccharidosis IIIC) is an early-onset neurodegenerative lysosomal storage disorder, which is currently untreatable. The vast majority of studies focusing on disease mechanisms of Sanfilippo syndrome were performed on non-neural cells or mouse models, which present obvious limitations. Induced pluripotent stem cells (iPSCs) are an efficient way to model human diseases in vitro. Recently developed transcription factor-based differentiation protocols allow fast and efficient conversion of iPSCs into the cell type of interest. By applying these protocols, we have generated newneuronal and astrocyticmodels of Sanfilippo syndrome using our previously established disease iPSC lines. Moreover, our neuronal model exhibits disease-specific molecular phenotypes, such as increase in lysosomes and heparan sulfate. Lastly, we tested an experimental, siRNA-based treatment previously shown to be successful in patients' fibroblasts and demonstrated its lack of efficacy in neurons. Our findings highlight the need to use relevant human cellular models to test therapeutic interventions and shows the applicability of our neuronal and astrocyticmodels of Sanfilippo syndrome for future studies on disease mechanisms and drug development. | - |
dc.format.extent | 15 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | MDPI | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.3390/jcm9030644 | - |
dc.relation.ispartof | Journal of Clinical Medicine, 2020, vol. 9, num. 644 | - |
dc.relation.uri | https://doi.org/10.3390/jcm9030644 | - |
dc.rights | cc-by (c) Benetó, Noelia et al., 2020 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es | - |
dc.source | Articles publicats en revistes (Genètica, Microbiologia i Estadística) | - |
dc.subject.classification | Malalties del sistema nerviós | - |
dc.subject.classification | Terapèutica | - |
dc.subject.classification | Malalties hereditàries | - |
dc.subject.other | Nervous system Diseases | - |
dc.subject.other | Therapeutics | - |
dc.subject.other | Genetic diseases | - |
dc.title | Neuronal and astrocytic differentiation from Sanfilippo C syndrome iPSCs for disease modeling and drug development | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 699336 | - |
dc.date.updated | 2021-02-25T17:51:23Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 32121121 | - |
Appears in Collections: | Articles publicats en revistes (Genètica, Microbiologia i Estadística) Articles publicats en revistes (Institut de Biomedicina (IBUB)) Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
699336.pdf | 2.59 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License